On December 9, China Merchants CSI Vaccine and Biotechnology ETF (561920) closed down 0.43%, with a turnover of 173,800 yuan.
Vaccine Leading ETF (561920) was established on March 15, 2023, and the full name of the fund is China Merchants CSI Vaccine and Biotechnology Exchange-traded Open-ended Index Securities Investment Fund, and the fund is referred to as China Merchants CSI Vaccine and Biotechnology ETF. The fund has a management fee of 0.50% per annum and a custody fee of 0.10% per annum. The performance of the leading vaccine ETF (561920) is based on the return rate of the CSI Vaccine and Biotechnology Index.
In terms of scale, as of December 6, the latest share of the vaccine leading ETF (561920) was 30.692 million shares, and the latest scale was 21.3893 million yuan. Looking back on December 29, 2023, the share of the vaccine leading ETF (561920) was 35.692 million shares, with a scale of 31.6088 million yuan. That is, the share of the fund has decreased by 14.01% and the scale has decreased by 32.33% since the beginning of this year.
In terms of liquidity, as of December 9, the cumulative turnover of the vaccine leading ETF (561920) in the past 20 trading days was 22.417 million yuan, with an average daily turnover of 1.1209 million yuan, and since the beginning of this year, the cumulative turnover in 226 trading days has been 196 million yuan, with an average daily turnover of 868,700 yuan.
The
current fund manager of the vaccine leading ETF (561920) is Hou Hao. Hou Hao has managed (or intends to manage) the fund since July 13, 2024, with a return of 16.56% during his tenure.
According to the latest regular report, the heavy stocks of the leading vaccine ETF (561920) include Zhifei Biotech, Wantai Biotech, Watson Biotech, Hualan Biotech, Kangtai Biotech, Changchun High-tech, Junshi Biosciences, Fosun Pharma, Gan & Lee Pharmaceutical, and BeiGene, with the following proportions.
| stock symbol | ,stock name | ,position ratio | , number of shares held (shares). | Market value of the position (RMB). |
| 300122 | Zhifei Biotech | 11.84%, | 75,72,526,100 | |
| 603392 | Wantai Biotech | 9.18%, | 23,901,958,300 | |
| 300142 | Walvax | Biotech 7.11% | 103,151.80 | |
| 002007 | Hualan Biotech | 5.92% | 70,51,262,900 | |
| 300601 | Kangtai Biology | 3.95%, | 43,100,842,900 | |
| 000661 | Changchun High-tech | 3.19%, | 6200.00 | 681,300 |
| 688180 | Junshi Biosciences | 2.93%, | 19,700,625,800 | |
| 600196 | Fosun Pharma | 2.81%, | 21,700,600,400 | |
| 603087 | Gan & Lee Pharmaceuticals | 2.81% | 1230006010 | |
| 688235 | BeiGene | 2.80% | 3312.00 | 597,700 |
Risk Warning: The market is risky, and investment needs to be cautious. This article is automatically released by the AI model, and any information appearing in this article (including but not limited to individual stocks, comments, forecasts, charts, indicators, theories, any form of expression, etc.) is for reference only and does not constitute personal investment advice. The MACD golden cross signal is formed, and these stocks are rising well!
Ticker Name
Percentage Change
Inclusion Date
